Parallax Volatility Advisers’s Enliven Therapeutics ELVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-24,775
Closed -$226K 1085
2022
Q3
$226K Buy
+24,775
New +$226K ﹤0.01% 610